Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Alnylam Pharmaceuticals (NQ: ALNY)
105.82 USD  +1.61 (+1.54%)
Official Closing Price  /  Updated: 5:04 PM EDT, Apr 3, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 501,400
Open 101.45
Bid (Size) 96.00 (1)
Ask (Size) 109.03 (1)
Prev. Close 104.21
Today's Range 100.02 - 105.98
52wk Range 65.81 - 134.51
Shares Outstanding 100,522,411
Dividend Yield N/A
Performance
YTD
-8.48%
-8.48%
1 Month
-9.74%
-9.74%
3 Month
-8.52%
-8.52%
6 Month
+37.39%
+37.39%
1 Year
+15.71%
+15.71%
Top News
More News
Vir and Alnylam Expand Collaboration to Advance Investigational RNAi Therapeutics Targeting Host Factors for the Treatment of COVID-19
Vir Biotechnology, Inc. (Nasdaq: VIR) and Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY) today announced an expansion to their broad multi-target existing collaboration for the development and... Read More
from Business Wire News Releases
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2019 Financial Results
from GlobeNewswire News Releases
More News
Read More
Vir Biotechnology Proceeding with Two Clinical Development Candidates for COVID-19
from GlobeNewswire News Releases
The Daily Biotech Pulse: Novartis Scraps Deal To Sell Sandoz Assets, Nevro Pre-Announces Q1 Shortfall, Affimed Granted Orphan Drug Designation
category coronavirus , Offerings , OPGN , and 21 more.
from Benzinga
FXH, DXCM, ALNY, SGEN: Large Inflows Detected at ETF
category ETFs
from ETF Channel
Noteworthy Monday Option Activity: WLK, ALNY, LULU
category Stocks
from Market News Video
Bullish Moving Average Cross by Alnylam Pharmace (ALNY)
from Comtex SmarTrend® News Briefs
Vir and Alnylam Expand Collaboration to Advance RNAi Therapeutics for the Treatment of Coronavirus Infection, Including COVID-19
from Business Wire News Releases
Relative Strength Alert For Alnylam Pharmaceuticals
category Stocks
from Market News Video
Analysts See 24% Gains Ahead For FXH
category ETFs
from ETF Channel
Better Coronavirus Stock: Inovio Pharmaceuticals vs. Vir Biotechnology
category ALNY , Market News , INO , and 1 more.
from Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.